State Street SPDR S&P Biotech ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 127.46
成立日期: 31/01/2006
 
分析
市值分佈:
65.29%
大市值
29.87%
中市值
7.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:54) 總持有投資項目: 145  
0%
 
100%
     10大 (16.71%)
代號 名稱 佔比% 持有日期
RIGLRigel Pharmaceuticals Inc0.3127/02/2026
MNKDMannKind Corp0.3127/02/2026
CTMXCytomX Therapeutics0.3127/02/2026
NRIXNurix Therapeutics0.3027/02/2026
PGENPrecigen0.2927/02/2026
GERNGeron Corp0.2927/02/2026
ORKAOruka Therapeutics Inc0.2827/02/2026
XNCRXencor0.2627/02/2026
VIRVir Biotechnology0.2527/02/2026
GLUEMonte Rosa Therapeutics0.2527/02/2026
SANASana Biotechnology0.2427/02/2026
OLMAOlema Pharmaceuticals0.2327/02/2026
REPLReplimune Group0.2227/02/2026
SPRYARS Pharmaceuticals0.2227/02/2026
KALVKalVista Pharmaceuticals0.2227/02/2026
BCAXBicara Therapeutics Inc.0.2127/02/2026
CGEMCullinan Therapeutics0.2027/02/2026
SIONSionna Therapeutics Inc0.1927/02/2026
PRMEPrime Medicine0.1827/02/2026
CMPXCompass Therapeutics0.1827/02/2026
  1    2    3    4    5   6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.